Literature DB >> 24305541

[Follicular lymphoma complicated with myelofibrosis and macroglobulinemia at initial presentation].

Hiroyuki Kuroda1, Tomoyuki Abe, Wataru Jomen, Masahiro Yoshida, Teppei Matsuno, Masanori Sato, Michiko Yamada, Tamaki Sakurai, Shigeyuki Fujii, Masahiro Maeda, Miri Fujita, Kazuo Nagashima, Kazuyuki Murase, Junji Kato.   

Abstract

A 49-year-old woman presented with pharyngeal and cervical lymph node swelling in December 2010. Biopsy of the pharynx demonstrated follicular lymphoma which secreted large volumes of immunoglobulin M (IgM) and transforming growth factor-β (TGF-β). Bone marrow aspiration yielded a dry tap, and bone marrow biopsy demonstrated myelofibrosis associated with lymphoma cells on admission. The plasma concentration of TGF-β was elevated and monoclonal IgM gammopathy was detected. After only one course of chemotherapy with CHOP plus rituximab, remission of both lymphoma and myelofibrosis was achieved. Bone marrow aspiration became possible, and TGF-β and IgM levels normalized. Thus, the myelofibrosis was reversible.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24305541

Source DB:  PubMed          Journal:  Rinsho Ketsueki        ISSN: 0485-1439


  2 in total

1.  Coexistence of follicular lymphoma and an unclassifiable myeloproliferative neoplasm in a treatment-naïve patient: A case report.

Authors:  Gyeongmin Jeong; Jinhyong Kim; Seeun Han; Jongmin Lee; Kyunghye Park; Chuiyong Pak; Ji-Hun Lim; Hee Jeong Cha; Hawk Kim; Jae-Cheol Jo
Journal:  Oncol Lett       Date:  2015-12-21       Impact factor: 2.967

2.  Simultaneous Follicular Lymphoma and Myelofibrosis: Report of a Case with Review of the Literature.

Authors:  Ling-Zhijie Kong; Jing Li; Rui-Cang Wang; Lin Kang; Qiang Wei; Yan Li
Journal:  Onco Targets Ther       Date:  2021-08-24       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.